Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Innocan Pharma Corp (INNO.CN)

Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Innocan Pharma to Present at the 2024 ThinkEquity Conference GlobeNewswire - Mon Oct 21, 8:30AM CDT

INNO.CN : 0.2300 (unch)
INNPF : 0.1055 (-34.10%)
Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience Newswire.ca - Wed Oct 16, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in chronic pain management via Liposomal CBD...

INNO.CN : 0.2300 (unch)
INNPF : 0.1055 (-34.10%)
Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs Newswire.ca - Fri Oct 11, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2300 (unch)
INNPF : 0.1055 (-34.10%)
Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide Newswire.ca - Wed Oct 9, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2300 (unch)
INNPF : 0.1055 (-34.10%)
Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting Newswire.ca - Tue Sep 3, 3:00PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2300 (unch)
INNPF : 0.1055 (-34.10%)
Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options Newswire.ca - Thu Aug 29, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2300 (unch)
INNPF : 0.1055 (-34.10%)
Innocan Pharma's Subsidiary BI Sky Global Successfully Completes FDA MoCRA Registration Newswire.ca - Thu Aug 22, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2300 (unch)
INNPF : 0.1055 (-34.10%)
Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million Newswire.ca - Mon Aug 12, 3:50PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 0.2300 (unch)
INNPF : 0.1055 (-34.10%)
Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center Newswire.ca - Fri Jul 26, 3:00PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2300 (unch)
INNPF : 0.1055 (-34.10%)
Innocan Pharma Engages Pain Management Expert in Preparation for Upcoming FDA Meeting Newswire.ca - Tue Jul 2, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2300 (unch)
INNPF : 0.1055 (-34.10%)

Barchart Exclusives

Valued at $3.43 Trillion, Is Nvidia Stock Really Undervalued? Barchart - 1 hour ago
SoftBank CEO Masayoshi Son has boldly claimed that Nvidia, already worth $3.4 trillion, is undervalued, citing the company's position at the heart of the artificial intelligence revolution. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot